Pfizer announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase...
metastasis
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and...
A new study found that regular physical activity, particularly walking, can significantly reduce cancer-related fatigue and improve...
Gynecological cancers, primarily cervical, ovarian, and uterine cancer, continue to be a significant threat to women’s health...
University of Warwick researchers have built a new diamond-based magnetic field sensor that could be used to...
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may...
The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, announced today that the U.S. Food and Drug...
Patients with newly diagnosed metastatic nonsquamous non-small cell lung cancer (NSCLC) who received pembrolizumab (Keytruda) plus chemotherapy...
Prostate cancer is the second most common cancer in men in the United States. The prostate is...
The European Medicines Agency (EMA) has recommended authorising Imlygic (talimogene laherparepvec) for the treatment of adults with...